Cargando…
Development, Molecular Docking, and In Silico ADME Evaluation of Selective ALR2 Inhibitors for the Treatment of Diabetic Complications via Suppression of the Polyol Pathway
[Image: see text] Diabetic complications are associated with overexpression of aldose reductase, an enzyme that catalyzes the first step of the polyol pathway. Osmotic stress in the hyperglycemic state is linked with the intracellular accumulation of sorbitol along with the depletion of NADPH and ev...
Autores principales: | Imran, Aqeel, Shehzad, Muhammad Tariq, Shah, Syed Jawad Ali, Laws, Mark, al-Adhami, Taha, Rahman, Khondaker Miraz, Khan, Imtiaz Ali, Shafiq, Zahid, Iqbal, Jamshed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352332/ https://www.ncbi.nlm.nih.gov/pubmed/35936488 http://dx.doi.org/10.1021/acsomega.2c02326 |
Ejemplares similares
-
Development and exploration of novel substituted thiosemicarbazones as inhibitors of aldose reductase via in vitro analysis and computational study
por: Imran, Aqeel, et al.
Publicado: (2022) -
Exploring synthetic and therapeutic prospects of new thiazoline derivatives as aldose reductase (ALR2) inhibitors
por: Shehzad, Muhammad Tariq, et al.
Publicado: (2021) -
Exploring Novel Pyridine Carboxamide Derivatives as Urease Inhibitors: Synthesis, Molecular Docking, Kinetic Studies and ADME Profile
por: Naseer, Ayesha, et al.
Publicado: (2022) -
Antibiotic resistance breakers: current approaches and future directions
por: Laws, Mark, et al.
Publicado: (2019) -
Structure based comprehensive modelling, spatial fingerprints mapping and ADME screening of curcumin analogues as novel ALR2 inhibitors
por: Verma, Sant Kumar, et al.
Publicado: (2017)